Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea
· Delayed Price · Currency is KRW 6,040.00
+30.00 (0.50%)
At close: Dec 5, 2025
Kyung Dong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 162,728 | 165,153 | 179,354 | 213,543 | 313,540 | 310,369 | Upgrade
|
| Market Cap Growth | -4.43% | -7.92% | -16.01% | -31.89% | 1.02% | 65.50% | Upgrade
|
| Enterprise Value | 168,559 | 175,958 | 152,976 | 187,326 | 269,370 | 225,665 | Upgrade
|
| Last Close Price | 6040.00 | 6130.00 | 6296.73 | 7055.36 | 9766.50 | 9157.35 | Upgrade
|
| PE Ratio | 19.69 | 30.19 | - | 17.56 | 24.74 | 24.91 | Upgrade
|
| Forward PE | - | 12.11 | 12.11 | 12.11 | 12.11 | 12.11 | Upgrade
|
| PS Ratio | 0.84 | 0.85 | 1.10 | 1.17 | 1.77 | 1.79 | Upgrade
|
| PB Ratio | 0.75 | 0.75 | 0.79 | 0.83 | 1.21 | 1.18 | Upgrade
|
| P/TBV Ratio | 0.77 | 0.77 | 0.81 | 0.84 | 1.22 | 1.19 | Upgrade
|
| P/FCF Ratio | 14.05 | - | - | - | 36.90 | - | Upgrade
|
| P/OCF Ratio | 7.90 | - | - | - | 25.24 | 18.13 | Upgrade
|
| EV/Sales Ratio | 0.87 | 0.91 | 0.94 | 1.02 | 1.52 | 1.30 | Upgrade
|
| EV/EBITDA Ratio | 15.18 | 21.88 | - | 12.48 | 11.83 | 8.52 | Upgrade
|
| EV/EBIT Ratio | 23.90 | 67.07 | - | 22.54 | 17.09 | 11.45 | Upgrade
|
| EV/FCF Ratio | 14.55 | - | - | - | 31.70 | - | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.18 | 0.07 | 0.10 | 0.02 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 2.68 | 4.81 | - | 1.79 | 0.19 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 2.63 | - | - | - | 0.51 | - | Upgrade
|
| Asset Turnover | 0.67 | 0.65 | 0.54 | 0.61 | 0.61 | 0.60 | Upgrade
|
| Inventory Turnover | 1.75 | 2.02 | 2.27 | 2.90 | 2.71 | 2.76 | Upgrade
|
| Quick Ratio | 0.61 | 0.70 | 0.89 | 1.41 | 2.82 | 3.07 | Upgrade
|
| Current Ratio | 1.34 | 1.29 | 1.52 | 2.05 | 4.07 | 4.22 | Upgrade
|
| Return on Equity (ROE) | 3.79% | 2.43% | -8.53% | 4.68% | 4.83% | 5.17% | Upgrade
|
| Return on Assets (ROA) | 1.57% | 0.55% | -5.17% | 1.73% | 3.38% | 4.25% | Upgrade
|
| Return on Capital (ROIC) | 1.81% | 0.65% | -5.91% | 1.89% | 3.72% | 4.68% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 1.20% | -10.70% | 3.20% | 5.90% | 7.40% | Upgrade
|
| Earnings Yield | 5.09% | 3.31% | -11.55% | 5.70% | 4.04% | 4.01% | Upgrade
|
| FCF Yield | 7.12% | -9.50% | -3.52% | -5.46% | 2.71% | -3.70% | Upgrade
|
| Dividend Yield | 4.97% | 4.89% | - | 5.67% | 5.12% | 5.46% | Upgrade
|
| Payout Ratio | 97.64% | 198.43% | - | 89.58% | 109.17% | 94.87% | Upgrade
|
| Buyback Yield / Dilution | 0.18% | 0.57% | 0.27% | 1.14% | -12.18% | -3.62% | Upgrade
|
| Total Shareholder Return | 5.14% | 5.46% | 0.27% | 6.81% | -7.06% | 1.84% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.